Detection of low-avidity CD4+ T cells using recombinant artificial APC: following the antiovalbumin immune response.
Subtle differences oppose CD4+ to CD8+ T cell physiologies that lead to different arrays of effector functions. Interestingly, this dichotomy has also unexpected practical consequences such as the inefficacy of many MHC class II tetramers in detecting specific CD4+ T cells. As a mean to study the CD4+ anti-OVA response in H-2(d) and H-2(b) genetic backgrounds, we developed I-A(d)- and I-A(b)-OVA recombinant MHC monomers and tetramers. We were able to show that in this particular system, despite normal biological activity, MHC class II tetramers failed to stain specific T cells. This failure was shown to be associated with a lack of cooperation between binding sites within the tetramer as measured by surface plasmon resonance. This limited cooperativeness translated into a low "functional avidity" and very transient binding of the tetramers to T cells. To overcome this biophysical barrier, recombinant artificial APC that display MHC molecules in a lipid bilayer were developed. The plasticity and size of the MHC-bearing fluorescent liposomes allowed binding to Ag-specific T cells and the detection of low numbers of anti-OVA T cells following immunization. The same liposomes were able, at 37 degrees C, to induce the full reorganization of the T cell signaling molecules and the formation of an immunological synapse. Artificial APC will allow T cell detection and the dissection of the molecular events of T cell activation and will help us understand the fundamental differences between CD4+ and CD8+ T cells.
Mallet-Designe
Valérie I
VI
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Stratmann
Thomas
T
Homann
Dirk
D
Carbone
Francis
F
Oldstone
Michael B A
MB
Teyton
Luc
L
D000818:Animals; D017951:Antigen Presentation / Q000235:genetics; D000938:Antigen-Presenting Cells / Q000276:immunology / Q000378:metabolism*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000378:metabolism*; D002448:Cell Adhesion / Q000276:immunology; D002449:Cell Aggregation / Q000235:genetics / Q000276:immunology; D002450:Cell Communication / Q000235:genetics* / Q000276:immunology*; D002645:Chickens; D004274:DNA, Recombinant / Q000276:immunology*; D018984:Epitopes, T-Lymphocyte / Q000032:analysis; D000949:Histocompatibility Antigens Class II / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D006801:Humans; D006825:Hybridomas / Q000737:chemistry; D007399:Interphase / Q000276:immunology; D008081:Liposomes / Q000032:analysis; D008213:Lymphocyte Activation / Q000235:genetics; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010047:Ovalbumin / Q000235:genetics* / Q000276:immunology* / Q000378:metabolism; D010446:Peptide Fragments / Q000235:genetics* / Q000276:immunology* / Q000378:metabolism; D012995:Solubility; D013194:Staining and Labeling; D020349:Surface Plasmon Resonance; D016176:T-Lymphocyte Subsets / Q000737:chemistry / Q000276:immunology
D004274:DNA, Recombinant; D018984:Epitopes, T-Lymphocyte; D000949:Histocompatibility Antigens Class II; D008081:Liposomes; C111390:OVA 323-339; D010446:Peptide Fragments; D010047:Ovalbumin